INS and hyperinsulinism: However, the maternal-derived or exogenously administered insulin does not cross the placenta, and the fetus responds to maternal hyperglycemia by hyperinsulinemia, which reduces fetal blood glucose levels, increases fetal adipose tissue, and enhances growth [39].